Skip to content

Prospective Observation of Wound Healing With Prevena Incision Management System

Prospective Observation of Wound Healing With Prevena Incision Management System

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01704924
Enrollment
0
Registered
2012-10-12
Start date
2012-10-31
Completion date
2016-12-31
Last updated
2018-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scarring

Keywords

Prevena, negative pressure wound therapy, Incisional wound vac

Brief summary

This study aims to assess the quality of wound healing in abdominal scars with and without the Prevena Incision Management System. The hypothesis is that Prevena will lead to improved wound healing with less swelling, bruising, and inflammation, as well as less potential for infection, seroma, and dehiscence.

Detailed description

The quality of wound healing can be of the utmost importance for patients undergoing large abdominal surgery. Incisional negative pressure wound therapy has been observed to decrease seroma and infection rates in high risk patients. This study aims to quantify the effect, if any, that negative pressure wound therapy has on closed incisions. The technology may provide benefits even in lower risk patients.

Interventions

DEVICEPrevena

Device will be applied at end of procedure over closed incision

Dressing applied as Standard of Care

Sponsors

University of California, Irvine
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* abdominal procedure with incision \>20cm * must be \>18 years of age

Exclusion criteria

* \<18 years of age * history of allergy or reaction to adhesives * pregnant or anticipated pregnancy within 6 months

Design outcomes

Primary

MeasureTime frameDescription
Scarring0-6 monthsAssess quality of scar: hypertrophy, hyperpigmentation, etc

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026